Home › Funds › Sculptor Capital LP › MRNA

Sculptor Capital LP position in MRNA

MODERNA INC · Health Care

Sculptor Capital LP reported holding 600,400 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$115.6M, representing 1.57% of its reported portfolio and ranking #13 among its reported holdings. Sculptor Capital LP first reported this position in Q3 2026.

Latest position (Q3 2026)600.40K sh
Reported value held$115.62M
Portfolio Weight1.57%
First reportedQ3 2026
Last changeNew
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Sculptor Capital LP's MRNA position evolved

Sculptor Capital LP first disclosed a stake in MRNA in Q3 2026 at 600,400 shares (US$115.6M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 600.40K $115.62M New

About MRNA and 13F data

MRNA (MODERNA INC) is a Health Care company. 42 other funds we track also report a position in MRNA — the largest reported positions include Fidelity Management & Research (FMR) (US$11.35B), Capital World Investors (US$4.36B), Baillie Gifford & Co (US$2.20B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRNA

All MRNA fund holders →

FAQ

How long has Sculptor Capital LP held MRNA?

Sculptor Capital LP has disclosed MRNA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Sculptor Capital LP's current position in MRNA?

As of Q3 2026, Sculptor Capital LP holds 600.40K shares of MRNA (MODERNA INC), valued at $115.62M, representing 1.57% of its reported portfolio and ranking #13.

Has Sculptor Capital LP been buying or selling MRNA?

In the latest 13F filing (Q3 2026), Sculptor Capital LP newly opened its position in MRNA.

Which other funds hold MRNA?

Other major institutional holders of MRNA include Fidelity Management & Research (FMR), Capital World Investors, Baillie Gifford & Co, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.